• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
HU Bingxue, DONG Xue, FAN Hongwei, ZHU Yongqiang, ZHANG Yin, ZHANG Zhao. Cardiotoxicity evaluation of three novel proteasome inhibitors in zebrafish[J]. Journal of China Pharmaceutical University, 2019, 50(4): 452-458. DOI: 10.11665/j.issn.1000-5048.20190410
Citation: HU Bingxue, DONG Xue, FAN Hongwei, ZHU Yongqiang, ZHANG Yin, ZHANG Zhao. Cardiotoxicity evaluation of three novel proteasome inhibitors in zebrafish[J]. Journal of China Pharmaceutical University, 2019, 50(4): 452-458. DOI: 10.11665/j.issn.1000-5048.20190410

Cardiotoxicity evaluation of three novel proteasome inhibitors in zebrafish

More Information
  • To evaluate the cardiotoxicity of three novel proteasome inhibitors(NNU395, NNU458 and NNU459)in zebrafish, normal developmental zebrafish embryos at 6 hours post fertilization(hpf)were treated with different doses of NNU395 and NNU458 and NNU459 until 72 hpf, the zebrafish mortality was counted. Morphologic changes of the cardiovascular system were observed under a stereomicroscope, and the number of heart beats within 1 min was determined. The expression of cardiac development-related genes in zebrafish was detected by RT-qPCR(Quantitative Real-Time PCR). Results showed that NNU395, NNU458 and NNU459 increased the mortality of zebrafish in a concentration-dependent manner and the values of LC50(50% lethal concentration)were(179. 7±12. 2), (27. 5±1. 3)and(24. 4±2. 6)μmol/L, respectively. Moreover, the toxicity of our three compounds in zebrafish are less when compared with their modified precursors. Upon administration of NNU395 at the concentrations of 120- 200 μmol/L, and NNU458 or NNU459 at the concentration of 30 μmol/L, the zebrafish showed obvious pericardial edema cardiac malformation. 120- 200 μmol/L NNU395 and 0. 1- 30 μmol/L NNU458 or 10- 30 μmol/L NNU459 significantly reduced the heart rate of zebrafish. All of three compounds at the tested concentration had no significant effects on the expression of the heart development-related genes in zebrafish. Our results suggested that low concentrations of NNU395, NNU458 and NNU459 have no obvious toxicity on cardiac development of zebrafish. While, higher concentrations of them showed cardiovascular toxicity on zebrafish.
  • [1]
    Liang JF,Jin WD,Li HW,et al.In vivo cardiotoxicity induced by sodium aescinate in zebrafish larvae[J].Molecules,2016,21(3):190.
    [2]
    Kantae V,Krekels EH,Ordas A,et al.Pharmacokinetic modeling of paracetamol uptake and clearance in zebrafish larvae:expanding the allometric scale in vertebrates with five orders of magnitude[J].Zebrafish,2016,13(6):504-510.
    [3]
    Macrae CA,Peterson RT.Zebrafish as tools for drug discovery[J].Nat Rev Drug Discov,2015,14(10):721-731.
    [4]
    Wang CM,Wei YJ,Jia XB.Evaluation of antiosteoporotic activity for micro-amount asperosaponins v and vi by on the osteoporosis model using zebrafish[J].J China Pharm Univ(中国药科大学学报),2014,45(1):88-91.
    [5]
    Brown DR,Clark BW,Garner LV,et al.Zebrafish cardiotoxicity:the effects of CYP1A inhibition and AHR2 knockdown following exposure to weak aryl hydrocarbon receptor agonists[J].Environ Sci Pollut Res Int,2015,22(11):8329-8338.
    [6]
    Simoneschi D,Simoneschi F,Todd NE.Assessment of cardiotoxicity and effects of malathion on the early development of zebrafish(danio rerio)using computer vision for heart rate quantification[J].Zebrafish,2014,11(3):275-280.
    [7]
    Li MM,Wang XJ,Zhu JG,et al.Toxic effects of polychlorinated biphenyls on cardiac development in zebrafish[J].Mol Biol Rep,2014,41(12):7973-7983.
    [8]
    Vargas RA.Effects of GABA,neural regulation,and intrinsic cardiac factors on heart rate variability in zebrafish larvae[J].Zebrafish,2017,14(2):106-117.
    [9]
    Cornet C, Calzolari S, Miñana-Prieto R, et al. ZeGlobalTox:an innovative approach to address organ drug toxicity using zebrafish[J].Int J Mol Sci,2017,18(4):E864.
    [10]
    Saley A,Hess M,Miller K,et al.Cardiac toxicity of triclosan in developing zebrafish[J].Zebrafish,2016,13(5):399-404.
    [11]
    Honton B,Despas F,Dumonteil N,et al.Bortezomib and heart failure:case-report and review of the French Pharmacovigilance database[J].Fundam Clin Pharmacol,2014,28(3):349-352.
    [12]
    Hasinoff BB,Patel D,Wu X.Molecular mechanisms of the cardiotoxicity of the proteasomal-targeted drugs bortezomib and carfilzomib[J].Cardiovasc Toxicol,2017,17(3):237-250.
    [13]
    Jouni H,Aubry MC,Lacy MQ,et al.Ixazomib cardiotoxicity:a possible class effect of proteasome inhibitors[J].Am J Hematol,2017,92(2):220-221.
    [14]
    Manasanch EE,Orlowski RZ.Proteasome inhibitors in cancer therapy[J].Nat Rev Clin Oncol,2017,14(7):417-433.
    [15]
    Gilda JE,Gomes AV.Proteasome dysfunction in cardiomyopathies[J].J Physiol(Lond),2017,595(12):4051-4071.
    [16]
    Barac YD,Emrich F,Krutzwakd-Josefson E,et al.The ubiquitin-proteasome system:a potential therapeutic target for heart failure[J].J Heart Lung Transplant,2017,36(7):708-714.
    [17]
    Food and Drug Administration HHS.International conference on harmonisation;guidance on S7B nonclinical evaluation of the potential for delayed ventricular repolarization(QT interval prolongation)by human pharmaceuticals;availability.notice[J].Fed Regist,2005,70(202):61133-61134.
    [18]
    Food and Drug Administration,HHS.International conference on Harmonisation;guidance on S7A safety pharmacology studies for human pharmaceuticals;availability.Notice[J].Fed Regist,2001,66(135):36791-36792.
    [19]
    Genge CE,Lin E,Lee L,et al.The zebrafish heart as a model of mammalian cardiac function[J].Rev Physiol Biochem Pharmacol,2016,171:99-136.
    [20]
    Zakaria ZZ,Benslimane FM,Nasrallah GK,et al.Using zebrafish for investigating the molecular mechanisms of drug-induced cardiotoxicity[J].Biomed Res Int,2018,2018:164284.
    [21]
    Milan DJ,Peterson TA,Ruskin JN,et al.Drugs that induce repolarization abnormalities cause bradycardia in zebrafish[J].Circulation,2003,107(10):1355-1358.
  • Related Articles

    [1]WU Jing, YU Xinyue, XU Yan, HUANG Yin, ZHANG Yuxin. Metabolomics profiling of doxorubicin-induced cardiotoxicity in mice with lung injury[J]. Journal of China Pharmaceutical University, 2023, 54(2): 198-207. DOI: 10.11665/j.issn.1000-5048.20221218001
    [2]XU Linhao, LIU Xinze, LIU Wei, XIANG Ping, HANG Taijun, YANG Shuo, YAN Hui. Application of zebrafish model in the metabolism of new psychoactive substances[J]. Journal of China Pharmaceutical University, 2022, 53(5): 606-612. DOI: 10.11665/j.issn.1000-5048.20220511
    [3]WAN Yili, ZHONG Hui, CHEN Li, SUN Jianbo. Synthesis,anti-melanoma activity and acute toxicity of aporphine alkaloids in zebrafish[J]. Journal of China Pharmaceutical University, 2021, 52(5): 529-535. DOI: 10.11665/j.issn.1000-5048.20210503
    [4]LIU Li, PEI Siran, WU Huali, ZHAO Qingshun, PENG Jixian, SHANG Jing. Drug screening model of treating pigmentation disorders in tyrp1a transgenic zebrafish[J]. Journal of China Pharmaceutical University, 2016, 47(6): 740-743. DOI: 10.11665/j.issn.1000-5048.20160618
    [5]JIANG Huiyong, YAN Yidan, LIU Haochen, ZHENG Yunsi, WANG Yixuan, HE Hua, LIU Xiaoquan. Evaluation of cardiotoxicity of doxorubicin in rat by a novel metabolic balance model[J]. Journal of China Pharmaceutical University, 2015, 46(2): 224-229. DOI: 10.11665/j.issn.1000-5048.20150215
    [6]GAO Xiaoping, CHEN Lixiao, YIN Zhiqi, JIANG Linlin, LIN Qinghua, HE Mingfang. Inhibitory effect of diarylheptanoids from Alpinia oxyphylla on angiogenesis[J]. Journal of China Pharmaceutical University, 2015, 46(1): 85-88. DOI: 10.11665/j.issn.1000-5048.20150112
    [7]WANG Changmei, JING Lijun, WEI Yingjie, JIA Xiaobin. Evaluation of antiosteoporotic activity for micro-amount asperosaponins V and VI by on the osteoporosis model using zebrafish[J]. Journal of China Pharmaceutical University, 2014, 45(1): 88-91. DOI: 10.11665/j.issn.1000-5048.20140116
    [8]WANG Xiaojian, FU Jihua, TANG Yiqun, YIN Dali, YOU Qidong. Synthesis,biological evaluation and molecule docking of novel desloratadine derivatives[J]. Journal of China Pharmaceutical University, 2013, 44(1): 39-43. DOI: 10.11665/j.issn.1000-5048.20130106
    [9]Antagonistic Effects of Extracts from Cultural Mycelium of Cordyceps sinensis on Cardiotoxicity Induced by Ouabain[J]. Journal of China Pharmaceutical University, 2000, (2): 40-42.
    [10]Colorimetric Determination of Residues of Tricaine in Fish[J]. Journal of China Pharmaceutical University, 1996, (3): 65-66.
  • Cited by

    Periodical cited type(3)

    1. 杜泽飞,张国文,孙健玮. 重楼中皂苷类成分抗肿瘤作用及机制研究进展. 云南医药. 2024(02): 73-75 .
    2. 刘天会. 细胞器之间相互作用在非酒精性脂肪性肝病发生发展中的作用. 临床肝胆病杂志. 2023(01): 181-187 .
    3. 曹守莹. 新型吡啶氮唑氮芥化合物与线粒体的作用及其抗肿瘤活性. 湖北理工学院学报. 2021(01): 56-61 .

    Other cited types(6)

Catalog

    Article views (587) PDF downloads (859) Cited by(9)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return